NCT02236520
Tissue Sodium in Pre-hypertensive Patients
See it on ClinicalTrials.gov ↗59 people
67.8%
32.2%
40 womenmiddle line = equal numbers19 men
- Phase
- PHASE2
- Paid for by
- Vanderbilt University
- Finished
- 2018-05-01
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 50 Years – 80 Years
- Average age
- mean 48 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 55.9% · Black / African American 44.1% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnancy;”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Postmenopausal women must be amenorrheic for at least 12 months in order not to be considered of child bearing potential. Pregnancy testing and contraception are not required for women with documented hysterectomy or tubal ligation.”
- No hormonal birth control
Women on the pill, patch, ring, shot, implant or hormonal IUD could not join.
“…eption during the study \[adequate contraceptive measures include stable use of oral contraceptives or other prescription pharmaceutical contraceptives for 2 or more menstrual cycles prior to screening; intrauterine device (IUD); bilateral…”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Morbid obesity (BMI \> 45);”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Acute cardiovascular events within the previous 6 months;”
- No diabetes
Women with diabetes were turned away.
“Diabetes mellitus requiring medical therapy;”
Study titles and rules are shown in their original English.